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Abstract.  18 
Fish can be exposed to a complex mixture of chemical contaminants, including 19 
pharmaceuticals, present in discharges of wastewater treatment works (WwTWs) effluents. 20 
There is little information on the effects of effluent exposure on fish metabolism, especially  21 
the small molecule signaling compounds which are the biological target of many 22 
pharmaceuticals. We applied a newly developed sensitive nanoflow-nanospray mass 23 
spectrometry non-targeted profiling technique to identify changes in the exposome and 24 
metabolome of roach (Rutilus rutilus) exposed to a final WwTWs effluent for 15 days. Effluent 25 
exposure resulted in widespread reduction (between 50% and 90%) in prostaglandin (PG) 26 
profiles in fish tissues and plasma with disruptions also in tryptophan/ serotonin, bile acid and 27 
lipid metabolism. Metabolite disruptions were not explained by altered expression of genes 28 
associated with the  PG or tryptophan metabolism. Of the 31 pharmaceutical metabolites that 29 
were detected in the effluent exposome of fish, 6 were non-steroidal anti-inflammatory drugs 30 
but with plasma concentrations too low to disrupt PG biosynthesis. PGs, bile acids and 31 
tryptophan metabolites are important mediators regulating a diverse array of physiological 32 
systems in fish and the identity of wastewater contaminants disrupting their metabolism 33 
warrants further investigation on their exposure effects on fish health. 34 
  35 
1. Introduction 36 
Fish inhabiting lowland rivers are often exposed to reductions in water quality caused 37 
by discharges of effluents from wastewater treatment works (WwTWs). Treated wastewaters 38 
contain a wide range of biologically active man-made chemicals including pharmaceuticals, 39 
personal care products and pesticides, which maybe incompletely removed during influent 40 
treatment resulting in their temporally varying concentrations in the receiving waters.1  Many 41 
studies have reported the presence of numerous pharmaceuticals from different therapeutic 42 
classes in final effluents and surface waters including non-steroidal anti-inflammatory drugs 43 
(NSAIDs), selective serotonin reuptake inhibitors (SSRIs), antipsychotics, statins and fibrates, 44 
beta blockers, and anticoagulants.1-3  Pharmaceuticals are designed to interact with high 45 
affinity with specific biological targets (e.g. receptors, enzymes) in humans and livestock (for 46 
veterinary pharmaceuticals) and these targets can be evolutionary conserved and functional 47 
in fish and other vertebrates,4 which may lead to unwanted pharmacological effects in non-48 
target species. A challenge for the environmental community is to prioritize chemicals for risk 49 
assessment and monitoring in order to improve the quality of surface and ground waters. 50 
The read-across hypothesis assumes that internal drug concentrations in blood plasma 51 
of wildlife which are similar to human therapeutic plasma concentrations (HtPC) may result 52 
iŶ eǆpeĐted ͚theƌapeutiĐ͛ effeĐts iŶ ŶoŶ-target organisms.5  For example, exposure to some 53 
anti-depressant SSRIs affect behavioural responses in fish at plasma concentrations similar to 54 
the HtPC.6,7 However, because fish populations can be exposed to complex mixtures of 55 
biologically active chemicals,8-10 identifying associations between exposure to their mixtures 56 
and health outcomes is extremely difficult.11  To date, most  analytical methods monitoring 57 
exposure of fish to effluents have used a targeted approach based on selection of key 58 
contaminants and metabolite pathways and are thus limited in their assessments of the risk 59 
of exposure to chemical mixtures.e.g 8-.10 An untargeted analytical approach based on liquid 60 
chromatography high resolution mass spectrometry (LC-MS) combined with chemometric 61 
pattern recognition can identify chemical mixtures accumulating in fish (i.e., the exposome) 62 
and simultaneously investigate for any associated disruption of metabolite profiles (the 63 
metabolome). Using this approach, previous studies have demonstrated that exposure to 64 
contaminants in wastewater effluents results in disruptions to lipid, steroid and bile acid 65 
metabolism and uptake of a variety of household and personal care products in fish blood 66 
plasma.e.g 12-14 However, until now metabolite profiling methods have not been able to detect 67 
trace levels of contaminants, endocrine or other signaling compounds present in tissues or 68 
plasma extracts. Recently, we have demonstrated that the detection of less abundant 69 
components in samples can be improved by using highly sensitive nanoflow/nanospray LC-70 
MS combined with appropriate sample preparation methods.15-17 An additional advantage of 71 
the method is that the chemical exposome, including pharmaceuticals, can also be profiled 72 
alongside the metabolome in the same sample. Hence, an untargeted analytical approach, 73 
based on nanoflow ultraperfomance liquid chromatography-nanoelectrospray ionization-74 
time-of-flight mass spectrometry (nUPLC-nESI-TOFMS) offers a very promising tool for 75 
advancing ecotoxicological investigations in fish exposed to the complex mixtures of 76 
contaminants present in WwTWs effluents. 77 
The aim of this study was to investigate the effects of exposure to a final treated 78 
wastewater effluent and the resultant uptake of a complex chemical exposome on the tissue 79 
and plasma metabolome of fish. Extracts of blood plasma and tissues from effluent-exposed 80 
and control fish were profiled using our newly developed nUPLC-nESI-TOFMS method in order 81 
to reach unprecedented levels of sensitivity and enable the detection of signaling compounds 82 
and contaminants present at very low concentrations. Our work revealed, for the first time, 83 
widespread disruption of signaling metabolites including prostaglandins (PGs), in tissues of 84 
effluent-exposed fish which could not be explained solely by the components of the 85 
pharmaceutical exposome known to target PG biosynthesis. As PGs are important signaling 86 
agents mediating a number of fish physiological processes, this study highlights the 87 
importance of understanding the mixture effects of contaminants present in wastewaters on 88 
fish health. 89 
2. Materials and Methods 90 
Sources of chemicals and standards are given in the Supporting Information. 91 
2.1 Effluent characteristics 92 
The WwTW chosen for this study received 95% influent from a domestic source 93 
(population equivalent of 117,574) and 5% input from industrial wastewaters.  The influent 94 
was treated by fine screens, chemically assisted settlement, biological aerated flooded filter 95 
processes and UV disinfection. During the exposure period, the pH of the effluent was 7.3, 96 
concentrations of suspended solids 21 mg/l, biochemical oxygen demand 11 mg/l, chemical 97 
oxygen demand 67 mg/l and total ammonia 29 mg/L (South West Water data). 98 
2.2 Fish exposure 99 
A mixed-sex population of sexually mature roach [Rutilus rutilus, age 2+, length of 14.5 100 
± 1.3 cm and weight 45.4 ± 12.1 g (mean ± SEM)] was exposed to either a final treated WwTWs 101 
effluent or clean water (control).  Roach were exposed in triplicate tanks (20 fish per 200 L 102 
tank) containing either dechlorinated water or 100% effluent for 15 days. The flow rate was 103 
10 L/min and the tanks were continually aerated with an average temperature of 12 ºC ± 1 104 
and a light dark cycle of 15h:9h. During the first 7 days of exposure, mortality occurred 105 
amongst 8 out of 60 of effluent-exposed fish, while no mortalities occurred in the control 106 
group.  At the end of the experimental period, fish were terminated using an overdose of 107 
phenoxyethanol according to UK Home Office regulations.  Blood was collected from the 108 
caudal vein using heparinized needles and samples were centrifuged (5 min, 10,000 RCF) and 109 
the plasma supernatant collected. Gonads, kidney (posterior), gill and liver tissues were 110 
dissected out aŶd iŵŵediatelǇ sŶap fƌozeŶ iŶ liƋuid ŶitƌogeŶ. All saŵples ǁeƌe stoƌed at −7Ϭ 111 
°C until analysis. 112 
Wastewater effluent samples (2 x 2.5 litres) were collected in solvent washed, acid 113 
rinsed amber glass bottles on days 0, 7, 15 of the exposure period. Samples were stored at 4 114 
°C with the addition of acetic acid (1%) and methanol (5%) and were extracted within 12 h 115 
after collection.  116 
2.3 Sample preparation for nUHPLC-nESI-TOFMS profiling 117 
Plasma samples were analyzed from up to 5 fish per replicate tank and in total 30 118 
females and 25 males were analyzed (males were present in lower proportion than females 119 
in the mixed sex population). Plasma samples (85-120 µL) were prepared as described in David 120 
et al.15 Previous studies have shown that this method, using phospolipid removal followed by 121 
mixed-mode cation exchange plates, extracts non polar, cationic and anionic metabolites 122 
(e.g., amino acids, neurotransmitters, bile acids, lipids, eicosanoids and steroids) as well as 123 
contaminants such as pharmaceuticals from plasma samples.  Briefly, methanol with 1% 124 
formic acid (FA) was added to each sample to a final proportion of 80/20 methanol/plasma 125 
(v/v). An internal standard (IS) mixture containing a mix of seven compounds (venlafaxine-d6, 126 
propranolol-d7, carbamazepine-d10 and fluoxetine-d5 for the +ESI mode and prostaglandin 127 
E2-d4, diclofenac-d4 and triclosan-C13 for the –ESI mode) was added to the plasma extracts. 128 
The amount of IS added were adjusted to give a final concentration of 5 ng IS/120 µL of 129 
plasma. Full details of plasma extraction using Phree and SPE plates are given in the 130 
Supporting Information.   131 
Testes (0.28-0.47 g), kidney (0.09-0.17 g), gill (0.28-0.47 g) and liver (0.09-0.20 g), 132 
tissues were extracted in glass tubes (5 mL) using three volumes of methanol and a Microson 133 
XL2000 ultrasonic probe (Misonix Farmingdale) (15W x 30s).18  Before extraction, the mix of 134 
seven IS was added to each tissue extract to give a final concentration of 5 ng IS to 0.4 g of 135 
testes, to 0.15 g of kidney or gill and to 0.35 g of liver. After extraction, samples were, 136 
centrifuged (13,000 RCF for 20 min) and supernatants collected. The samples were diluted to 137 
20% water (HPLC grade) and extracted using the Phree and SPE plates (see Supporting 138 
Information).  139 
2.4 Extraction of wastewater samples for nUHPLC-nESI-TOFMS analysis of NSAIDs. 140 
Final wastewater effluent samples (1 L) were spiked with the IS mix, and filtered 141 
through glass wool and filter paper Whatman No1 (Whatman, Maidstone, UK). Samples were  142 
extracted through an Oasis HLB (20 mL, 1 g) cartridge, which was pre-conditioned with 10 mL 143 
of methanol and 10 mL HPLC water. The cartridge was washed with 20 mL of distilled water 144 
and dried under vacuum. Analytes were eluted with 10 mL of methanol and 10 mL of ethyl 145 
acetate. Extracts were dried and reconstituted in 1 mL of methanol and 300 mL of the extract 146 
evaporated and purified using the Strata-X-C SPE protocol as described for tissue samples. 147 
2.5 nUHPLC-nESI-TOFMS 148 
The methods used for the nUHPLC-nESI-TOFMS profiling of small molecules have been 149 
established in our laboratory.15, 17 The nUHPLC-nESI-TOFMS injections were performed on a 150 
Waters nanoAcquity UPLC linked to a Waters Xevo G2 TOFMS, equipped with a nESI source 151 
(Waters, Manchester, U.K) (see Supporting Information for analytical details).  152 
2.6. Quality control 153 
For the metabolomics analysis, two work-up samples (i.e. extraction without sample) 154 
per analytical batch were prepared to monitor for background contaminants.  Quality control 155 
(QC) samples comprising a composite sample of the control extracts (diluted two fold) were 156 
prepared in order to monitor for nUHPLC-nESI-TOFMS repeatability and sensitivity during 157 
analysis of a sample run. Each run commenced with the injection of the blank work-up 158 
samples followed by injection of 3 QC samples to equilibrate the source. The samples were 159 
injected randomly with QC samples analysed after every 6 samples. In total, 151 samples 160 
(excluding QCs) were injected in both +ESI and -ESI MS modes.  161 
2.7 Chemometric analyses 162 
Mass spectra were collected in full scan mode (50 to 1000 m/z) and spectral peaks 163 
were deconvoluted and aligned using TransOmics algorithm (Waters, Manchester, UK). Peak 164 
picking was performed creating an aggregate dataset from all sample files in which the MS 165 
features were binned into retention time (Rt) x m/z values. Datasets were exported to SIMCA 166 
software (Umetrics, Crewe, UK) for multivariate analysis (principal component analysis, PCA) 167 
in order to examine class separating differences between control and exposed groups. Data 168 
sets were log transformed and pareto scaled, and models were developed using the database 169 
of n (from 10 to 15) different fish per class. PCAs were performed in order to observe 170 
clustering between treatments, and models were evaluated through an examination of 171 
explained variation (R2X) and predictive ability (Q2X) parameters. In order to determine 172 
which contaminants and metabolites influence discrimination between two classes, the 173 
datasets were modelled using orthogonal partial least squares to latent structures (OPLS) 174 
method which were assessed by the explained variation (R2Y) and predictive ability (Q2Y). Rt 175 
x m/z signals pertaining to discriminatory contaminants or metabolites were detected using 176 
aŶ ͚S͛ plot of the OPLS ŵodel. e.g. 13, 18, 19 Signals associated with the presence of chemical 177 
contaminants arising from effluent exposure were identified as only present in effluent- 178 
exposed fish and not detected in any replicates from control fish or from work-up blank 179 
samples. Signals corresponding to metabolite markers were either decreased in control fish 180 
or increased in effluent-exposed fish but also present in control fish but not in work-up blanks. 181 
The signal intensity of suspected metabolite markers of effluent exposure were normalized 182 
to the area of the closest IS.   Analysis, using the Kruskal-Wallis test, of replicate fish from each 183 
of the triplicate tanks from the two exposure treatments revealed no significant intertank 184 
variability for any metabolite marker. Hence, metabolites from fish from replicate tanks were 185 
analyzed as one treatment for each exposure by non-parametric Mann-Whitney U-test (SPSS, 186 
IBM) with a correction for a false discovery rate of 5%.20 187 
The putative identities of contaminants and metabolites were determined from 188 
screening the m/z of molecular ion using Metabosearch 189 
(http://omics.georgetown.edu/metabosearch.html) which searched databases of the Human 190 
Metabolome Database (http://www.hmdb.ca/), PubChem 191 
(http://pubchem.ncbi.nlm.nih.gov/), METLIN (http://metlin.scripps.edu/) and LipidMaps 192 
(http://www.lipidmaps.org/). Chemical identity was confirmed from accurate mass, isotopic 193 
fit and fragmentation data obtained from high energy collisional-induced dissociation and 194 
from comparison in- house with standard compounds or with open source databases.   195 
2.8 Targeted analysis of NSAIDs by nUHPLC-nESI-TOFMS 196 
NSAIDs were quantified in the profiling datasets of tissues and plasma and also after 197 
nUHPLC-nESI-TOFMS analysis of wastewater extracts (see Supporting Information for details) 198 
Method detection and method quantification limits (MDLs, MQLs) are given in  Tables S1 and 199 
S5. 200 
2.9 Gene expression analysis 201 
Quantitative real-time RT-PCR (RT-QPCR) was performed on male and female gill, liver 202 
and gonad tissue samples to quantify the expression profiles of transcripts encoding enzymes 203 
for which related metabolites were found to change in the prostaglandin and serotonin 204 
pathways.  The targets were prostaglandin-endoperoxide synthase 1 (ptgs1), prostaglandin-205 
endoperoxide synthase 2b (ptgs2b), prostaglandin E synthase (ptges) and cytosolic 206 
phospholipase A2 (pla2g4) in the prostaglandin pathway and monoamine oxidase (mao), 207 
dopa decarboxylase (aromatic amino acid decarboxylase, ddc), aldehyde oxidase 1 (aox1), 208 
tryptophan 2,3-dioxygenase a (tdo2a) and tryptophan 2,3-dioxygenase b (tdo2b) in the 209 
serotonin pathway.  Details on RNA analyses, primer sequences, sizes of PCR products and 210 
PCR assay conditions are provided in Supporting Information and Table S2. Samples from 3 211 
fish per tank were analysed and the ChauǀeŶet͛s ĐƌiteƌioŶ21 was applied to detect any outliers 212 
in the transcript expression data.  Identified outliers were removed from the data set prior to 213 
statistical analyses.  Data were analyzed using a t-test comparing transcript expression 214 
between all control and exposed fish and results of all tests were accepted as significant at p 215 
< 0.05 (IBM SPSS Statistics for Windows, Version 21.0.0). 216 
  217 
3. Results and Discussion  218 
3.1 nUHPLC-nESI-TOFMS profiling of roach plasma and tissues 219 
Extracts of blood plasma from male and female roach exposed to either a treated 220 
WwTWs effluent or to clean water were profiled by nUPLC-nESI-TOFMS in both +ESI and -ESI 221 
modes. PCA modeling of the datasets revealed clear separation between control and effluent-222 
exposed roach of both sexes on the first component of the scores plots (-ESI mode Figure 1, 223 
+ESI mode, Figure S1). In these plots, the QC samples clustered together indicating that the 224 
profiling methods were highly repeatable with little analytical variability. The datasets were 225 
further analyzed by OPLS modeling which revealed highly predictable models for control and 226 
exposed datasets from either male or female roach (R2Y of >0.99 and Q2Y>0.69). No 227 
separation according to sex was observed in effluent-exposed roach in either the PCA or OPLS 228 
models indicating that the response (in terms of plasma chemical profiles) to effluent 229 
exposure was similar in female and male fish.  Therefore, female tissue samples (gills, liver 230 
and the posterior kidney which contains both renal cells and macrophages) were analyzed as 231 
they were available in greater numbers than males. Extracts of testes tissue from males were 232 
also profiled because it is known that PGs play important roles in sexual differentiation22 and 233 
the association between exposure to WwTWs effluents and feminization of male fish has 234 
been well documented.e.g.23 The PCA of the datasets of all tissue extracts revealed a clear 235 
separation between samples from control and exposed fish (Figure S2). 236 
3.2 Metabolite markers of effluent exposure  237 
Fƌoŵ aŶalǇsis of the ͚ S͛ loadiŶg plots of the OPLS ŵodels of the plasma datasets, it was 238 
apparent that most of the chemicals driving the separation between control and effluent-239 
exposed fish were contaminants which were only detected in plasma of exposed fish (see 240 
section 3.3 below). However, ten metabolite structures were identified as significant markers 241 
of effluent exposure (Table 1). In agreement with a previous study,14 exposure to WwTWs 242 
effluent resulted in disrupted metabolism of plasma bile acids and lipids. After effluent 243 
exposure, the plasma concentrations of two conjugated secondary bile acids were increased 244 
by 5-12 fold (female and male fish) for taurodeoxycholic acid, and 39-56 fold for a 245 
taurolithocholic acid-like structure. No changes in the levels of primary bile acids, such as 246 
taurocholic acid and cyprinol sulfate, were detected. Little is known about the effect of 247 
chemical exposures on disruption of bile acid profiles in fish or mammals, however secondary 248 
bile acids are formed by the metabolism of gut microflora.24,25 It is possible that the observed 249 
increase in metabolism of secondary bile acids was a result of disruption of the community or 250 
gene expression of resident gut bacteria as a result of exposure to chemical components in 251 
the effluent. Increases in the lipid metabolite sphinganine (9- fold) and its potential precursor, 252 
a palmitoyl serine type metabolite (177-227 fold), were also observed indicating disruption in 253 
sphingolipid signaling.    254 
In our study, the use of more sensitive nanoflow/nanospray LC-MS profiling methods 255 
resulted in detection of new metabolites in effluent-exposed fish that were associated with 256 
other signaling pathways. These included a 5-11 fold increase in the plasma concentration of 257 
tryptophan and a 2-fold decrease in its metabolite acetylserotonin, indicating effects on the 258 
serotonin pathway (Table 1). ͚S͛ plot aŶalǇsis of OPLS ŵodels of ŵetaďolite pƌofiles iŶ tissues 259 
revealed that concentrations of indolepyruvate, a metabolite of tryptophan, were increased 260 
by 13 and 32-fold in female gills and male testes, respectively (Table S3), indicating that 261 
tryptophan metabolism was also altered in these tissues as well as in blood plasma of effluent-262 
exposed roach. In order to explore the mechanisms responsible for these metabolite changes, 263 
selected gene transcripts associated with tryptophan/serotonin metabolism were analyzed 264 
by qRT-PCR  in gills, liver and gonads of male and female fish (Figure S3). Tryptophan can be 265 
metabolized by dioxygenases and a decrease in their expression would result in an increased 266 
substrate for metabolism to acetyl serotonin or indolepyruvate.26 However, the dioxygenase 267 
(tdo2a) transcript was only significantly decreased in male and female liver from exposed fish 268 
and was increased in male gills. Significant increases in the dopa decarboxylase transcript 269 
levels (ddc) which metabolizes tryptophan to serotonin, and monamine oxidase expression 270 
(mao) which further converts serotonin to hydroxyindole acetic acid,27 were observed only in 271 
female gills and for ddc also in female liver. Taken together, effluent exposure did not result 272 
in a widespread alteration in the transcription of key genes that could explain the changes 273 
involved in tryptophan metabolism in roach tissues.    274 
Concentrations of a number of eicosanoid type metabolites were also altered in 275 
plasma samples from effluent-exposed male and female fish. These included a 10-15-fold 276 
reduction in prostaglandin F2α (PGF2α) levels, a 5-fold decrease in a tetranor PGE1-like 277 
structure, and a 13-16- fold increase in an oxygenated C20 metabolite (dicarboxy leukotriene 278 
B4-like) (Table 1). EǆaŵiŶatioŶ of the ͚S͛ plots fƌoŵ OPLS models of female gills, liver, kidney 279 
and male testes revealed numerous signals, mainly corresponding to prostaglandin 280 
structures, which were prevalent (depressed) markers of effluent exposure (Table S3). PGE2 281 
and PGF2α levels were reduced by 52-90% in all the tissues analyzed, together with a mean 282 
93% reduction observed for PGF2α in plasma (Figure 2).  Reductions in levels of a further 7 283 
different prostaglandin metabolites were detected in various body tissues (Table S3) and 284 
further work is needed to determine their structural identity. 285 
The widespread reduction of prostaglandin structures in tissues and in blood plasma 286 
indicates a general inhibition of the prostaglandin metabolism in effluent-exposed fish. 287 
Prostaglandins are formed from the action of prostaglandin endoperoxide synthases (PGTS), 288 
also termed cyclooxygenase enzymes, on the C20 polyunsaturated fatty acid, arachidonic 289 
acid, which in turn is released from membrane phospholipids by the action of cytosolic 290 
phospholipase A2 (PLA2).  At least two PTGS genes (pgts 1 and 2) are present in fish and qRT-291 
PCR analysis of gills, liver and gonads of male and female fish revealed that their expression 292 
was not altered as a result of effluent exposure (Figure S3). Expression of pla2g4, associated 293 
with substrate release by PLA2, was reduced in liver and gills of males but not in females or 294 
in gonads of either sex. Likewise, pgtes, which encodes PGE synthase and conversion of the 295 
PGH2 intermediate to PGE2, was reduced in liver and gills of males but not females, nor in 296 
gonads of either sex. These data indicate that the widespread reduction of PG levels in the 297 
various body tissues were not due to changes in expression of genes associated with their 298 
biosynthesis, but rather may arise from direct inhibition of enzyme activity instead. 299 
The functional role and the identities of the full complement of biologically active 300 
prostaglandin structures has not been not fully determined in fish systems. However, PGE2 301 
regulates ion transport in fish gills and kidney28, macrophage differentiation in the posterior 302 
kidney, and is an important inflammatory and blood clotting mediator produced by leucocytes 303 
and thrombocytes.29 PGF2α is can regulate reproductive behavior, synchronous spawning, 304 
and ovulation in females.30  PGs are also important signaling agents during cell development 305 
and differentiation.31  This indicates that widespread reduction of PG levels may have 306 
deleterious effects affecting numerous endpoints in fish including development, 307 
reproduction, the immune response and osmoregulation.  308 
The role of other metabolites identified in our study has yet to be fully understood in 309 
fish physiology. However, there remains the possibility that the roles of serotonin, bile acid 310 
and PG metabolites maybe linked, or act in concert, to affect health in fish. For instance, a 311 
follow-up study of brain tissue sampled from fish used in this study revealed significant 312 
increases of serotonin concentrations in selected brain regions of the effluent-exposed fish 313 
(A David, pers comm). Serotonin regulates aggression32 and PGFϮα mediates courtship in 314 
male fish,33 which indicates that further investigations on the effects of wastewater exposures  315 
on disruption of fish behaviour are warranted.  Similarly, serotonin and PG metabolites are 316 
both signalling agents in the hypothalamus-pituitary-gonad axis of fish and regulate gonadal 317 
development.22,34 They are also both important modulators of the immune and inflammatory 318 
response of vertebrates, 29, 35 and both regulate  epithelial cell function in gills. 28,36  In 319 
mammals, some secondary bile acids, including taurodeoxycholic acid, can act as anti-320 
secretory agents in the colon,37 whereas both serotonin and prostaglandin metabolites 321 
promote epithelial mucosal secretion and gastrointestinal protection38,39 raising the question 322 
as to whether interactions occur between these different metabolites affecting 323 
gastrointestinal function in fish.  324 
 325 
3.3 The link between the exposome and metabolome of effluent-exposed fish 326 
IŶteƌƌogatioŶ of the ͚S͛ loadiŶg plots of sigŶals uŶiƋue to efflueŶt-exposed fish 327 
revealed the accumulation of a complex mixture of contaminants in blood plasma and tissues. 328 
These contained 31 pharmaceuticals from 11 different classes including NSAIDs (naproxen, 329 
mefenamic acid, diclofenac, ibuprofen, felbinac, celecoxib) and SSRIs (paroxetine, citalopram, 330 
sertraline, fluoxetine, norfluoxetine, norsertraline and norcitalopram) (Figure 3 and Table S4).  331 
In addition, a wide range of endocrine disrupters, personal care products, pesticides, 332 
antibacterial and human dietary products were also detected in the plasma and tissues of 333 
effluent-exposed but not control fish (Table S4). 334 
Due to matrix interferences, the concentrations of SSRIs in the different sample types 335 
could not be determined in this study and their quantitative analysis required further method 336 
development.  However, the concentrations of NSAIDs, which are potent inhibitors of PGTS 337 
enzymes in vertebrate systems, were determined in effluent and fish samples.  During the 338 
exposure period, NSAIDs levels in the effluent were all below 0.5 µg/l, except for naproxen 339 
which was present at a mean ± SD of 3.7 ± 2.3 µg/l (Tables 2 and S5).  Studies to date indicate 340 
that these concentrations of NSAIDs were too low to affect PG or PGTS gene expression levels 341 
in fish.40-42 In addition, NSAID concentrations in plasma and tissues of effluent-exposed fish 342 
were determined and compared with reported human therapeutic plasma concentrations, 343 
HtPC43 (Table 2).  NSAIDs were detected in plasma and most of the tissues analyzed, but with 344 
the exception of naproxen and ibuprofen, their mean concentrations were  < 1ng/ml plasma 345 
or 1 ng/g tissue.  Mean concentrations of naproxen and ibuprofen in the plasma were higher 346 
than in the effluent indicating bioconcentration of these contaminants in the fish. The effluent 347 
concentrations of naproxen were above the MQL, which allowed the determination of a 348 
plasma bioconcentration factor of 4, similar to that already reported for this compound.44 349 
However, the plasma concentrations of all NSAIDs were between 650 and 14,0000-fold below 350 
the HtPC. As PG levels were significantly reduced in blood plasma and body tissues, this would 351 
indicate that either NSAIDs and their mixtures were more potent in fish compared with 352 
humans, or that other contaminants were present that inhibited PG biosynthesis in the fish. 353 
Previous reports suggest that many other compounds can inhibit PGTS enzyme activity, 354 
including pesticides and some of the endocrine disrupting chemicals detected in fish in this 355 
study (Table S4).45,46  Further work is needed to identify other PGTS inhibitors amongst the 356 
diverse range of contaminants which bioconcentrate in fish exposed to WwTW effluents.  357 
3.4 Implications of the work and future studies. 358 
This study was conducted with undiluted effluent, which reflects the exposures of 359 
aquatic animals, including fish, in some countries where there is little or no dilution of the 360 
discharges into the receiving waters.47 However, there was a mortality of 13% during effluent 361 
exposure indicating that fish were subjected to high physiological stress. Further studies are 362 
required to determine whether similar metabolite disruptions are observed with diluted 363 
effluents that typify ambient waters.  364 
Through the application of newly developed sensitive non-targeted chemical profiling 365 
techniques, a novel finding emerging is the widespread reduction in PG metabolism in the 366 
roach exposed to a final treated WwTWs effluent.  This finding could not have been predicted 367 
from an analysis of pharmaceuticals in the effluent which are designed to target PG 368 
metabolism, and there is a need to identify the key causative contaminants disrupting  PG 369 
biosynthesis in WwTW effluents.  Moreover, we highlight the need for further understanding 370 
on the identity and function of the numerous PG metabolites that were detected in fish 371 
tissues. Furthermore, PGs, serotonin and bile acid metabolites are components of key 372 
signaling pathways which mediate gastrointestinal function, ion transport, immune and 373 
reproductive processes in vertebrates, and disruption in their levels may potentially impact 374 
on a range of health endpoints in contaminated fish.  375 
Our study further emphasizes the importance of understanding mixture effects of 376 
contaminants (including their metabolites) on the health of wildlife.  Improvements in 377 
discovery-based chemical profiling technologies are likely to increase coverage of the 378 
exposome and metabolome, and advance our understanding of the link between exposure to 379 
complex mixtures of contaminants and their impact on multiple metabolite pathways. 380 
However, it will require a step change in knowledge to understand the link between 381 
disruption of multiple interacting pathways and their consequent effects on wildlife or human 382 
health. Without this knowledge, environmental policymakers may have to consider whether 383 
regulation of chemical contaminants should be proactive and informed by changes in 384 
molecular profiles with the potential for physiological disruption, rather than a reliance on 385 
demonstrated health endpoints which may take many decades to investigate, particularly in 386 
respect to exposure of chemical mixtures. 387 
Supporting Information  388 
Supporting information comprises further analytical details, PCA score plots of metabolomics 389 
datasets and tables of identification of markers of effluent exposure. This material is available 390 
free of charge via the Internet at http://pubs.acs.org. 391 
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Table 1. The effect of exposure to wastewater effluent on blood plasma metabolite profiles of roach. 
Retention 
time 
Observed 
molecular ion 
Molecular 
ion species 
Δ ppŵ Formula of ion Fragment 
ions 
Kegg no Identity Fold 
change 
p value Fold 
change 
P value 
Metabolites decreased in plasma      Female Male 
6.19 219.1136 M+H 0.9 C12H15N2O2 160.0766 C00978 acetylserotonin a 1.6 0.014 2.7 2.8x10-4 
13.61 353.2326 M-H -0.6 C20H33O5 309.2058 C00639 PGFϮα a 10.6 3.7x10-5 14.7 2.6x10-4 
14.20 297.1702 M-H 0 C16H25O5 nd - tetranor PGE1  like 5.2 4.0x10-6 4.8 8.5x10-5 
Metabolites increased in plasma          
15.80 383.2068 M-H -0.5 C20H31O7 nd - dicarboxy LTB4 like 16.6 6.1 x 10-6 13.3 8.1 x 10-5 
14.74 498.2889 M-H 0 C26H44NO6S nd  taurodeoxycholic 
acid a 
5.1 1.3x10-4 12.1 1.2x10-4 
C05122 
19.29 482.2939 M-H -0.2 C26H44NO5S nd C02592 taurolithocholic acid 
like 
39.3 2.0x10-6 56.0 2.6x10-5 
6.01 205.0979 M+H 0.1 C11H13N2O2 188.0713, 
146.0606 
C00078 tryptophan a 5.0 4x10-3 10.7 4.0x10-4 
4.27 204.0662 M+H 0.5 C11H10NO3 158.0605, 
130.0658 
C00331 Indolepyruvatea 22.9 2.1x10-5 77.6 5.6x10-5 
15.59 302.3060 M+H 0.3 C18H40NO2 284.2952 C00836 sphinganine 9.1 6.4 x 10-5 9.4 5.2 x 10-5 
25.19 352.2828 M+Na 0 C19H39NO3Na 312.2898   palmitoyl serine  like 227 4.5x10-5 177 3.0x10-4 
a metabolite identity confirmed by a pure standard. Other metabolite structures determined from comparison of CID fragments with MS dataďases.   Δ ppŵ 
difference between observed and calculated molecular ion.  nd= not detected.  Metabolites disrupted by effluent exposure were determined from P values 
calculated using Mann Whitney test and after correction for a false discovery rate of 5%. n=10 and n=13 for control and exposed males; n=13 and n=16 for 
control and exposed females. 
 
 
 Table 2. Concentrations of nonsteroidal anti-inflammatory drugs in effluent, blood plasma and tissues of effluent-exposed roach and human 
therapeutic plasma concentrations (HtPC). 
  
   
Effluenta 
ng/ml 
(n=6) 
plasma ♀ 
ng/ml 
(n=16) 
plasma ♂ 
ng/ml 
(n=13) 
gills 
ng/g 
(n=10) 
kidney 
ng/g 
(n=12) 
liver 
ng/g 
(n=12) 
testes 
ng/g 
(n=12) 
HtPC b 
ng/ml 
 
Naproxen Range 2.0 - 7.7 5.2 - 27 6.7 - 22 3.3 - 6.9 3.5 - 16 12 - 351 <0.11d - 1.9 20000 - 50000 
 Mean±SD 3.7 ± 2.3 13 ± 6.2 14 ± 4.6 5.1 ± 1.2 8.2 ± 3.8 75 ± 91 0.93 ± 0.48  
Felbinac Range <0.25c 0.36 - 1.1 <0.19d- 0.84 0.19-0.23 0.58 - 0.97 3.5 - 8.7 0.056 - 0.11 400 - 1000 
 Mean±SD <0.25c 0.65 ± 0.15 0.57 ± 0.27 0.21 ± 0.01 0.77 ± 0.1 5.7 ± 1.6 0.091 ± 0.013  
Diclofenac Range 0.22 - 0.38 <0.30d - 1.9 <0.1 - 0.82 0.35 -1.0 <0.24d- 0.35 <0.21d - 0.31 <0.03c - 0.32 500 - 3000 
 Mean±SD 0.35 ± 0.10 0.43 ± 0.45 0.39 ± 0.27 0.58 ± 0.21 0.13 ± 0.10 0.21 ± 0.09 0.09 ± 0.09  
Ibuprofen Range <0.01c <7.5d - 13 <7.5d - 14 <2.0 c - <6.0d <2.0 - <6.0d <1.7c - <5.1d <0.75c -< 2.3d 15000 - 30000 
 Mean±SD <0.01c 5.2 ± 3.7 5.8 ± 4.3 <2.0 c <2.0 c <1.7c <0.75c  
Celecoxib Range 0.013 – 0.018 0.30 - 0.32 0.29 - 0.31 0.23 - 0.25 0.35 - 0.37 0.36 - 0.41 <0.019c - 0.094 360 - 800 
 Mean±SD 0.015 ± 0.002 0.31 ± 0.01 0.30 ± 0.01 0.24 ± 0.01 0.36 ± 0.003 0.38 ± 0.01 0.091 ± 0.001  
Mefenamic  Range 0.08 – 0.15 <0.94d - 1.2 <0.94d - 1.3 <0.25 c - 0.75d 0.94 - 1.0 1.0 - 1.7 <0.094c - <0.28d 2000 - 10000 
acid Mean±SD 0.10 ± 0.03 0.70 ± 0.40 0.79 ± 0.42 <0.25c 0.98 ± 0.03 1.2 ± 0.18 <0.09c  
aEffluent samples measured at 0, 7, and 15 days of exposure. Plasma and tissue samples analysed at the end of the 15 day exposure period.   bHtPC 
from Shultz et al.43  c = MDL value, d =  MQL value. SD= standard deviation. For the mean calculations, all concentrations that were over the limits of 
deteĐtioŶ ;≥MDLͿ ďut ďeloǁ the liŵits of ƋuaŶtifiĐatioŶ ;<MQLͿ ǁeƌe assigŶed the ǀalue ĐoŶsideƌed as the MDL iŶ eaĐh Đase. Concentrations 
below the MDL were considered to be zero. Gills, kidney and liver samples were from females only.  NSAID levels in control fish were below the 
MDL values given in Table S1. 
Figure captions. 
Figure 1. Principal component analysis scores plot of the chemical profiles in plasma of roach (male and female) exposed either to a final 
treated WwTWs effluent or clean water. 
Extracts were profiled in -ESI mode by nUPLC-nESI-TOFMS. Quality control (QC) samples were used to monitor the analytical performance of the 
MS platform. % R2X values are given on the respective components. MC= male control, FC=female, control, FE=female effluent, ME= male effluent.   
 
Figure 2.  EffeĐt of efflueŶt exposure oŶ PGE2 aŶd PGF2α ĐoŶĐeŶtratioŶs iŶ fish tissues aŶd ďlood plasŵa  
PGEϮ aŶd PGFϮα ĐoŶĐeŶtƌatioŶs ǁeƌe ŵeasuƌed fƌoŵ the ŵeaŶ ;± staŶdaƌd deǀiatioŶͿ ƌelatiǀe aďuŶdaŶĐe Đoŵpaƌed to the iŶteƌŶal standard.  The 
% reduction in PG concentrations in the effluent-exposed group were determined from the mean values in the control fish which had been 
normalised to 100% for each tissue type. **p<0.01;***p<0.001;****p<0.0001. n=10 and n=13 for control and exposed male plasma; n=13 and n=16 
for control and exposed female plasma; n=12 and n=12 for control and exposed testes; n=10 and n=12 for control and exposed kidney; n=14 and 
n=12 for control and exposed liver; n=11 and n=10 for control and exposed gills, respectively. PGE2 was not detected in any plasma sample,  MDL; 
method detection limit.   
 
Figure 3. Number and classes of pharmaceuticals detected in the blood plasma and tissues of roach exposed to a WwTW effluent.  
NSAIDs, non-steroidal anti-inflammatory drugs.  SSRIs, selective serotonin reuptake inhibitors. In total, 31 pharmaceuticals were detected across 
the different tissues and the identities of 26 were confirmed by pure standards (see Table S4). No pharmaceuticals were detected in samples from 
control fish. 
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